| Title |
Effects of MTX-23, a Novel PROTAC of Androgen Receptor Splice Variant-7 and Androgen Receptor, on CRPC Resistant to Second-Line Antiandrogen Therapy
|
|---|---|
| Published in |
Molecular Cancer Therapeutics, March 2021
|
| DOI | 10.1158/1535-7163.mct-20-0417 |
| Pubmed ID | |
| Authors |
Geun Taek Lee, Naoya Nagaya, Jenny Desantis, Kiran Madura, Hatem E Sabaawy, Wun-Jae Kim, Roy J Vaz, Gabriele Cruciani, Isaac Yi Kim |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 25% |
| Germany | 1 | 5% |
| Japan | 1 | 5% |
| Canada | 1 | 5% |
| Italy | 1 | 5% |
| France | 1 | 5% |
| Unknown | 10 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 55% |
| Scientists | 9 | 45% |
Mendeley readers
The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 62 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 17 | 27% |
| Student > Ph. D. Student | 8 | 13% |
| Student > Bachelor | 6 | 10% |
| Other | 3 | 5% |
| Student > Doctoral Student | 2 | 3% |
| Other | 6 | 10% |
| Unknown | 20 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Chemistry | 11 | 18% |
| Biochemistry, Genetics and Molecular Biology | 10 | 16% |
| Agricultural and Biological Sciences | 5 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 6% |
| Medicine and Dentistry | 4 | 6% |
| Other | 7 | 11% |
| Unknown | 21 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2021.
All research outputs
#3,388,170
of 25,734,859 outputs
Outputs from Molecular Cancer Therapeutics
#481
of 4,088 outputs
Outputs of similar age
#86,702
of 454,482 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#11
of 75 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,088 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,482 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.